What is Caplin Point Laboratories Earnings Yield (Joel Greenblatt) %?
Caplin Point Laboratories's Enterprise Value for the quarter that ended in Mar. 2024 was ₹92,006 Mil.
Caplin Point Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹5,652 Mil. Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2024 was 6.14%.
The historical rank and industry rank for Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
BOM:524742'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.34 Med: 6.64 Max: 26.88
Current: 6.26
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Caplin Point Laboratories was 26.88%. The lowest was 2.34%. And the median was 6.64%.
BOM:524742's Earnings Yield (Joel Greenblatt) % is ranked better than 72.19% of 1093
companies
in the Drug Manufacturers industry
Industry Median: 2.57
vs BOM:524742: 6.26
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Caplin Point Laboratories's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2024 was 20.50%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Caplin Point Laboratories Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Caplin Point Laboratories Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) %
For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) % falls into.
Caplin Point Laboratories Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Caplin Point Laboratoriess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2024 is calculated as
Caplin Point Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,652 Mil.
Caplin Point Laboratories (BOM:524742) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Caplin Point Laboratories Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Caplin Point Laboratories's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Caplin Point Laboratories (BOM:524742) Business Description
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524742 has been successfully added to your 